TQ Therapeutics has acquired Juno GmbH to enhance its decentralised, automated cell and gene therapy platform. This acquisition provides TQx with access to key intellectual property and licensing agreements, enabling the development of a bedside-compatible system aimed at reducing production times and enhancing scalability in extracorporeal cell therapy. This strategic move not only strengthens TQ […]
Tag: Acquisition
Growing Pharma Tuck-In Deals Post-Mediocre Small Biotech Q1
Following a lackluster first quarter for small biotechs, the pharmaceutical industry is witnessing a surge in tuck-in deals. Ventyx, with upcoming Phase II Parkinson’s disease results, struck a deal with Sanofi granting the pharma right of first negotiation (ROFN) on an acquisition. This agreement, driven by a shared interest in novel central nervous system therapies, […]
Mullen Automotive’s Strategic Moves: Reverse Split, GEM Settlement & $1.4M Order
Mullen Automotive, amidst challenges and opportunities, undertakes key strategic decisions. The company recently implemented a 1-for-100 reverse stock split effective June 2, 2025. Additionally, Mullen settled a longstanding legal dispute with GEM Group, leading to a pause in collection efforts and potential acquisition of its Mishawaka facility, along with an expansion of the Tunica plant […]
Pharma Boosts R&D Investment Despite Challenges
Despite political and economic challenges, Merck CEO Robert Davis remains optimistic about the company’s ophthalmology business. The recent acquisition of EyeBio brought a $1.3 billion boost, focusing on the trispecific antibody Restoret for diabetic macular edema (DME) and neovascular age-related macular degeneration (AMD). The Phase IIb/III trial for Restoret in DME, known as BRUNELLO, commenced […]
Salesforce’s Strategic Acquisition Journey
In late 2022, Salesforce faced pressure from activist investors critiquing its revenue growth, cost management, and M&A strategy. This led to strategic ties between CEOs and the eventual acquisition of Informatica. The acquisition showcased Salesforce’s patient approach and the importance of CEO relationships in the business landscape. The episode highlights the complex interplay between shareholder […]
Beowolff Capital’s $65M Acquisition of Artnet Signifies Strategic Shift
When artnet AG went public in 2000, it was a pioneer in the art industry’s digital expansion. Beowolff Capital’s recent $65M acquisition of Artnet suggests a strategic pivot, reflecting the evolving art market landscape driven by A.I. advancements. Artnet CEO Jacob Pabst views this acquisition as a crucial moment for innovation and product development, anticipating […]
Optimizing Business Acquisition with Strategic Loans
Established in 2006, Signature Bank is a state-chartered bank serving Illinois and Wisconsin. Known for its relationship-based approach, the bank emphasizes customer service and prudent business operations. With a focus on technology and strong capitalization, Signature Bank has rapidly grown to become one of the leading independent business banks in the Midwest. Notably, it has […]
Insights on CVS Health from 10 Analyst Ratings
CVS Health is a prominent player in the healthcare industry, offering a wide range of services. With over 9,000 retail pharmacy stores in the US, CVS also functions as a major pharmacy benefit manager, processing a staggering 2 billion claims annually. Additionally, the company operates a leading health insurer, catering to approximately 27 million medical […]
Alto Neuroscience Acquires Intriguing Depression Asset
Alto Neuroscience’s recent acquisition of ALTO-207, described as an ‘intriguing asset’ by William Blair, has garnered attention for its impressive efficacy in the PAX-D study. While pramipexole showed promise, concerns about functional unblinding in the study have been raised, potentially impacting the perceived efficacy. This move highlights the company’s commitment to expanding its portfolio in […]
Zydus Strengthens Biologics Presence Through Agenus Deal
Zydus has solidified its position in the global biologics market through the acquisition of Agenus, which includes biologics manufacturing sites in Emeryville and Berkeley, California. The deal involves an upfront payment of $75 million, with an additional $50 million in milestone-based payments over three years. These facilities will support Zydus’ new biologics CDMO business, catering […]
Key Biotech News: Lyra’s Success, Sanofi’s Acquisition
In the latest biotech updates, Lyra Therapeutics celebrates a significant achievement while Sanofi makes a notable acquisition. These developments highlight the dynamic nature of the biotech industry in Boston, a hub for groundbreaking research and innovation. With biotech jobs on the rise in Massachusetts, the challenges of hiring skilled professionals remain a key focus for […]
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Illinois Court Upholds AbbVie, Allergan Merger Suit Dismissal
In a recent development, an Illinois appellate court has upheld a lower court’s decision to dismiss a challenge regarding AbbVie Inc.’s acquisition of Allergan Plc. The court ruled that Allergan shareholders were adequately informed by an Irish court about a fairness hearing and were given the opportunity to participate in the hearing with legal representation. […]
